Article

BMI alone does not predict prostate cancer recurrence, death

Body mass index does not appear to independently predict long-term prostate cancer survival after radical prostatectomy

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Man talking with doctor | Image Credit: © Khunatorn - stock.adobe.com
1 expert is featured in this series.
Related Content
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
May 9th 2025

Durvalumab plus BCG significantly improves DFS in NMIBC

Benjamin P. Saylor Hannah Clarke
The data are to be presented at an upcoming medical conference.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
May 4th 2025

Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
Stent omission after ureteroscopy is safe, improves patient-reported outcomes
May 8th 2025

Stent omission after ureteroscopy is safe, improves patient-reported outcomes

Hannah Clarke
Patient-reported pain scores were significantly improved with stent omission.
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
May 1st 2025

Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025

Amy M. Pearlman, MD
Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
May 7th 2025

Physical function and frailty measures offer distinct insights in patients with bladder cancer

Hannah Clarke
Data showed that physical function and self-reported frailty assessments were poorly correlated.
FDA to host advisory committee meeting on UGN-102 for NMIBC
May 7th 2025

FDA to host advisory committee meeting on UGN-102 for NMIBC

Hannah Clarke
The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.
© 2025 MJH Life Sciences

All rights reserved.